| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |